[Cancerogenicity of cytostatics].
D000477:Alkylating Agents / Q000494:pharmacology; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001379:Azathioprine / Q000009:adverse effects; D002471:Cell Transformation, Neoplastic / Q000139:chemically induced; D003609:Dactinomycin / Q000009:adverse effects; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008727:Methotrexate / Q000009:adverse effects; D008938:Mitosis / Q000187:drug effects; D009369:Neoplasms / Q000139:chemically induced*; D012333:RNA, Messenger / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D051381:Rats
D000477:Alkylating Agents; D000970:Antineoplastic Agents; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D003609:Dactinomycin; D001379:Azathioprine; D008727:Methotrexate
Zur Frage der Kanzerogenität von Zytostatika.